Eye implants make vision-restoring progress
(Medical Xpress) -- "I was blind once but now I can see. The words are no longer the sole property of religious testimony and literature. Medical progress is being made in the restoration of vision as evidenced by Second Sights Argus II, a retinal prosthesis already on the market in Europe, and Bio-Retina from NanoRetina, which is to start clinical trials next year. Second Sight is a California company with a European office in Lausanne. Its Argus II Retinal Prosthesis System was developed to provide electrical stimulation of the retina to induce visual perception. The Argus II is an eye implant system that includes antenna, electronics case and electrode array. The $115,000 procedure entrails a four hour operation under full anesthesia.
The prosthesis provides electrical stimulation of the retina that can elicit visual perception in blind people with severe to profound retinitis pigmentosa. The system includes an antenna, an electronics case, and electrode array. External equipment includes special glasses, a video processing unit (VPU) and a cable.
The Argus II was designed to bypass damaged photoreceptors altogether. The way the system works is that a video camera in the glasses captures a scene. The video is sent to a small patient-worn computer VPU where it is processed and transformed into instructions sent back to the glasses via a cable. These instructions are transmitted wirelessly to the antenna in the implant. The signals are sent to the electrode array, which emits small pulses of electricity. The pulses bypass the damaged photoreceptors and stimulate the retinas remaining cells, which transmit the visual information along the optic nerve to the brain.
The result delivers greater independence for patients. Users of the Argus II bionic eye say that they can see rough shapes and track the movement of objects; they can slowly read large writing.
This video is not supported by your browser at this time.Anticipation is high, meanwhile, for a bionic retina that has been designed to restore sight at less cost and with a different technique. The Bio-Retina developed by Nano Retina does not make use of an external camera; instead, a vision-restoring sensor is placed inside the eye, on top of the damaged retina. This is a 24×24-resolution (576-pixel) sensor atop the damaged retina. The device generates a grayscale image.
The implant is inserted through an incision in the eye. The procedure takes 30 minutes and requires only local anesthesia. Bio-Retina transforms naturally received light into an electrical signal that stimulates the neurons, which send the pictures received by Bio-Retina to the brain. A rechargeable, battery-powered mini-laser on a pair of eyeglasses powers the implant wirelessly. After a patient undergoes the procedure, the anticipated recover time is up to one week. Also anticipated is instantaneous restoration of vision, with patients able to distinguish faces and to be able to look from side to side with their eyes rather than needing to turn their heads.
More information: www.nano-retina.info/
© 2012 Medical Xpress
- USC researchers begin tests on next generation of retinal implant Feb 16, 2007 | not rated yet | 0
- Popular Mechanics award given to artificial retina team Sep 30, 2010 | not rated yet | 0
- Artificial retina helps some blind people Feb 14, 2011 | not rated yet | 0
- Researchers' vision: restoring sight through artificial retinas Dec 30, 2008 | not rated yet | 0
- 'Bionic eye' implant offers hope to the blind Apr 03, 2011 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Is energy convertible to matter?
1 hour ago Can we convert energy to matter?
Rotating electron as a dipole is this right?
3 hours ago An electron as shown by the Stern Gerlach experiment behaves like a dipole (albeit only in one of two states). I have been trying to figure out how...
Dipole term in multipole expansion
7 hours ago Hi. I'm having some difficult in understanding something about the dipole term in a multipole expansion. Griffiths writes the expansion as a sum of...
Bubbles in a Pre-Boiling/Boiling pot of water
9 hours ago How is it that bubbles form on the bottom of a surface of a pot of boiling water? I think that there is probably an elementary answer to this...
Assumptions of Griffith's fracture theory
19 hours ago Any experts on Griffith's fracture theory? I am studying the subject and I am having hard time finding out if the theory is valid for all possible...
Current leading voltage or vice versa concept
21 hours ago Hello, I was wondering if there is a conceptual explanation for when current leads voltage or vice versa for capacitors or inductors with AC...
- More from Physics Forums - Classical Physics
More news stories
Prostaglandin analogues (PGAs), drugs which lower intraocular pressure, are often the first line of treatment for people with glaucoma, but their use is not without risks. PGAs have long been associated with blurred vision, ...
Ophthalmology 10 hours ago | not rated yet | 0
(Medical Xpress)—Exposure to sunshine as a small child is crucial to the development of a healthy eye according to results of long-term myopia study conducted by University of Sydney researchers.
Ophthalmology 15 hours ago | 5 / 5 (1) | 0
The most common cause of failure after glaucoma surgery is scarring at the surgical site, so researchers are actively looking for ways to minimize or prevent scar formation. Previous work had suggested that vascular endothelial ...
Ophthalmology May 17, 2013 | not rated yet | 0 |
New research is emphasizing the importance of regular screenings for glaucoma, a disease that deteriorates the optic nerve over time and is a leading cause of irreversible blindness worldwide. The onset of glaucoma is associated ...
Ophthalmology May 17, 2013 | not rated yet | 0 |
The University of Nottingham and Nottingham University Hospitals NHS Trust, have been working with Sony Computer Entertainment Europe (SCEE) to develop special 3-D glasses and games to help treat children ...
Ophthalmology May 08, 2013 | not rated yet | 0
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
10 hours ago | 4 / 5 (4) | 0 |
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
8 hours ago | 4.8 / 5 (6) | 0 |
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
4 hours ago | 5 / 5 (1) | 0
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...
4 hours ago | 5 / 5 (3) | 0 |
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
10 hours ago | 4.8 / 5 (4) | 0 |
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.
5 hours ago | not rated yet | 0 |